IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+4.48%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-8.3%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-9.26%
Top 10 Holdings %
Top 10 Hldgs %
51.54%
Holding
77
New
13
Increased
17
Reduced
12
Closed
16
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.4M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$8.92M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.89M |
| 4 |
Gilead Sciences
GILD
|
$6.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$6.65M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$40.5M |
| 2 |
Alkermes
ALKS
|
$16.7M |
| 3 |
Exelixis
EXEL
|
$10.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$8.48M |
| 5 |
Sanofi
SNY
|
$7.81M |
Sector Composition
| 1 | Healthcare | 99.7% |